Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 04, 2021 08:00 ET | Source: Applied Genetic Technologies Corporation

AGTC Advances in AAV Gene Therapy Manufacturing to be Presented at the American Society of Gene & Cell Therapy 24th Annual Meeting

GAINESVILLE, Fla. and CAMBRIDGE, Mass., May 04, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
May 03, 2021 08:39 ET | Source: Applied Genetic Technologies Corporation

AGTC Clinical Investigators Provide Encore Presentation of Data from the Company’s Ongoing XLRP and Achromatopsia Phase 1/2 Trials

-Company remains on track to present additional 12-month data from the XLRP and achromatopsia clinical trials in the second quarter of 2021- ALACHUA, Fla. and CAMBRIDGE, Mass., May 03, 2021 (GLOBE...
April 29, 2021 07:30 ET | Source: Applied Genetic Technologies Corporation

AGTC Announces Data to be Presented from the Ongoing XLRP and Achromatopsia Clinical Trials at the ARVO 2021 Virtual Annual Meeting

GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
April 26, 2021 16:02 ET | Source: Applied Genetic Technologies Corporation

AGTC Announces Departure of Chief Scientific Officer

GAINESVILLE, Fla. and CAMBRIDGE, Mass., April 26, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
April 19, 2021 07:00 ET | Source: Applied Genetic Technologies Corporation

AGTC licenses Promoter Technology to SparingVision SAS

-Technology To Be Incorporated In Multiple SparingVision SAS Programs- ALACHUA, Fla. and CAMBRIDGE, Mass., April 19, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq:...
April 13, 2021 07:00 ET | Source: Applied Genetic Technologies Corporation; TeamedOn International, Inc.

TeamedOn and AGTC Announce a Licensing Agreement Advancing X-Linked Retinoschisis Gene Therapy Program

- AGTC Transfers Clinical Trial Materials and Phase 1/2 Data To TeamedON - ROCKVILLE, Md., April 13, 2021 (GLOBE NEWSWIRE) -- TeamedOn International, Inc., a biotechnology company dedicated to...
March 31, 2021 08:00 ET | Source: Applied Genetic Technologies Corporation

AGTC to Participate in Upcoming Virtual Biotech Corporate Access Day and Cell and Gene Conference

GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 31, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...
March 25, 2021 07:00 ET | Source: Applied Genetic Technologies Corporation

AGTC Announces New Initiatives To Enhance The Patient Journey In Its XLRP Trials

-AGTC’s deep commitment to the patient voice drives solutions to support patient access to information and to improve the experience of patients participating in clinical trials- GAINESVILLE, Fla.,...
March 18, 2021 12:00 ET | Source: Applied Genetic Technologies Corporation

AGTC to Present at the Gene Therapy Patient Engagement Summit, Held Virtually, March 24, 2021

-AGTC will highlight the value of the patient voice in gene therapy development- GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 18, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation...
March 02, 2021 07:00 ET | Source: Applied Genetic Technologies Corporation

AGTC to Present at Upcoming Investor Conferences

GAINESVILLE, Fla. and CAMBRIDGE, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of...